Colchicine for people with chronic kidney disease
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether colchicine, a drug that reduces inflammation, can help prevent further heart problems or strokes in people with moderate chronic kidney disease. You may be eligible if you have kidney disease and have had a heart attack, stroke, or related event in the past.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 99 years old.
- You have moderate chronic kidney disease (a specific measure of kidney function between 30 and 59).
- You have had a past heart attack, unstable angina, stroke (not caused by a blood clot from the heart), or a blocked artery in your legs or elsewhere.
- You are not currently taking colchicine or have stopped it for at least one month.
- You have no active cancer (except certain skin cancers) or serious infections like hepatitis or HIV.
- You are not pregnant, breastfeeding, or planning to become pregnant, and you agree to use highly effective birth control if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a low dose of colchicine, a medicine that reduces inflammation, can help improve blood vessel and bone health in people with moderate chronic kidney disease.
This Phase 2 trial tests whether colchicine can reduce inflammation and improve heart function in people with kidney disease and a certain type of heart problem. If you qualify, you’ll be closely monitored for side effects and lab changes.
This trial tests whether taking colchicine can prevent coronary artery disease (heart artery blockages) in people who have several heart risk factors but do not already have diagnosed disease. It aims to see if colchicine lowers the chance of developing heart artery problems over time.
This trial tests whether a low dose of the anti-inflammatory drug colchicine can help people who have recently had a heart attack or unstable angina. It aims to see if colchicine reduces the risk of future heart problems.
This trial tests if colchicine, an anti-inflammatory medicine, can help people with a type of heart failure where the heart pumps well but is stiff and inflamed. You may join if your heart failure recently worsened and you have signs of inflammation in your blood.
This study tests if colchicine, a medicine used for gout and inflammation, can help people with coronary heart disease who have had a stent placed. You might be eligible if you have ongoing inflammation (measured by a simple blood test) and are already on standard heart medications.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.